Dendreon Corporation (Nasdaq: DNDN) is a Seattle-based biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system Immune SystemThe complex group of organs and cells that defends the body against infections and other diseases.Closeto fight cancer. CancerCancer develops when cells in the body begin to grow out of control. Normal cells grow, divide, and die. Instead of dying, cancer cells continue to grow and form new abnormal cells. Cancer cells often travel to other body parts where they grow and replace normal tissue. This spreading process is called metastasis. When cancer spreads or metastasizes, it is still named after the part of the body where it started. For example, if prostate cancer spreads to the bones, it is still prostate cancer, not bone cancer. Some cancers, such as blood cancers, do not form a tumor. Not all tumors are cancer. A tumor that is not cancer is called benign and does not grow and spread the way cancer does.Close

Through innovative science and technology, we are striving to develop and commercialize products that address unmet medical needs, improve survival and have a favorable safety profile.

DIVERSIFIED PRODUCT PORTFOLIO
Dendreon has a diversified product portfolio consisting of Active Cellular Immunotherapy (ACI), monoclonal antibody and small molecule product candidates in clinical and pre-clinical development for a variety of cancers.

LEAD PRODUCT CANDIDATE NEARING COMMERCIALIZATION
The dedication of our research and development team has resulted in our lead product on the brink of commercialization. Dendreon's lead ACI candidate, sipuleucel-T, is in late-stage development for the treatment of asymptomatic, metastatic, androgen-independent Androgen-IndependentTerm for prostate cancer cells that no longer respond to hormone therapy; also known as hormone-refractory. Close(also known as hormone-refractory) prostate ProstateA gland in the male reproductive system. The prostate surrounds the part of the urethra (the tube that empties the bladder) just below the bladder, and produces a fluid that forms part of the semen.Closecancer.